A neurologist took DIY treatments seriously. Has it sparked a breakthrough?
Dr. Bedlack discusses ALSUntangled — a group dedicated to investigating alleged or emerging ALS treatments.
Health Beat: Stopping seizures & saving lives
Dr. Zafar discusses how a hemispherectomy eliminated epileptic seizures in a young patient.
Duke Neurology Research Round Up | June 2024
Richard Bedlack, MD, PhD contributed to an original paper in Muscle & Nerve that shared
NeuroVoices: Katherine Peters, PhD, on Vorasidenib’s Impact on Quality of Life, Neurocognition, and Seizures in the Treatment of Gliomas
Dr. Peters provides clarity on a new analysis of the INDIGO study highlighting treatment benefits of vorasidenib in patients with IDH mutant grade 2 gliomas.
Are migraines getting worse?
Dr. Collins comments on how the climate crisis could impact migraine frequency and intensity.
2024 Michelle Winn Awards Celebrate Achievements in Equity, Diversity, and Inclusion
Andy Liu, MD, Kim Johnson, MD, and Burt Scott, MD, PhD were recipients of this year's Michelle P. Winn Inclusive Excellence Award.
This woman has ALS. So did 22 of her relatives. What she wants you to know.
Dr. Bedlack comments on the use of Qalsody and its impact on ALS patients with the SOD1 gene.
Staff Spotlight: Charalambos "Bobby" Charalambous, PhD
Read about Charalambos "Bobby" Charalambous, PhD and his role and research mission as a Medical Instructor in the Department of Neurology.